Beff (e/acc)
So the real reasons that Anthropic nerfed Fable for biology and ML weren't for "Safety" but because those are markets they wanted to dominate. Got it.
Andrew Curran
Anthropic has told investors in pre-IPO meetings that it plans to lean harder into biology and healthcare applications to help mitigate the increasingly negative public sentiment against the industry. A few miracle cures would certainly do wonders to turn things around.
